A man in Oklahoma City who used a fake Amazon van to transport pot has been sentenced to nine years in federal prison, according to a press release from the U.S. Department of Justice (DOJ).
An emerging alternative to psychedelic mushrooms is more dangerous than advertised, public health researchers are warning.
A potential depression treatment might someday come from trip-inducing toad venom. In a new study Wednesday, researchers appear to have deciphered the structural workings of a psychedelic compound derived from the Colorado River toad (Incilius alvarius). The team also tested a modified version of the compound in mice,…
CBD for your chronic pain may turn out to be a dangerous dud, the authors of a large review say. They found little evidence from clinical trials that CBD can be an effective pain reliever. These products also tend to have inaccurate labeling information about the amount of CBD they contain or even other undisclosed…
New Yorkers will finally be able to grow their own thanks to new ordinances set for a vote by the state’s Cannabis Control Board. If the proposed regulations are finalized, state residents will be allowed to cultivate up to 12 cannabis plants and keep 5 pounds of self-produced cannabis flower in their shoebox…
The psychedelic drug ibogaine may be able to give brain injury sufferers some much needed help. A new, small study found that military veterans with a history of traumatic brain injury experienced a significant improvement in their symptoms of depression, anxiety, and PTSD following treatment with ibogaine and…
Researchers in Australia have analyzed the genomes of over 100 commercial and wild-grown varieties of Psilocybe cubensis, a psychoactive fungi known as the magic mushroom. The findings may eventually help growers develop “designer shrooms” that have their own unique health benefits, the team says.
The results of a Phase III trial published this week could soon lead to a new era for the treatment of post-traumatic stress disorder. The study found that a combination of MDMA and psychotherapy was effective at relieving PTSD symptoms when compared to standard therapy. The nonprofit organization funding this…
New research out this week is the latest to show that psilocybin—the active ingredient in magic mushrooms—can be a viable treatment for depression. The randomized Phase II trial found that a single dose of psilocybin combined with therapy significantly reduced people’s depression symptoms when compared to placebo over…
Twitter’s ad revenue may have gone up in smoke recently, but the company isn’t letting that get it down. Instead, it’s taking the high road and adjusting for headwinds.